320 SOQUEL WAY, SUNNYVALE, CA
Files Request for Meeting with FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
Reports 2025 Business Highlights and Financial Results
Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA
Late Breaking Echocardiography Clinical Results from HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno
FY 2025
Q3
Amended Quarterly Report
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload